Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
From one busy year to another
January 7, 2025
A New Year’s message from ACP Council president Patrick Zachar.
Read more ➞